Recently, there has been doubt about the usefulness of AFP testing for early diagnosis of HCC [5–7] but its utility remains in areas where the prevalence of HCC is high, as reflected in some guidelines for HCC surveillance [8, 9]. This evidence concerns the gene AFP and hepatocellular carcinoma.